21st Century Neurology, a division of Xenoscience — Phoenix, Arizona

21st Century Neurology, a division of Xenoscience is a clinical research site located in Phoenix, Arizona, United States 85013.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

21st Century Neurology, a division of Xenoscience has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Alzheimer's Disease, Migraine, Episodic Migraine.

Sponsors: Cerecin, Eli Lilly and Company, Sumitomo Pharma America, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Phoenix

Browse all research sites in Arizona · View every site in Phoenix

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 21st Century Neurology, a division of Xenoscience?

21st Century Neurology, a division of Xenoscience has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 21st Century Neurology, a division of Xenoscience conducted?

21st Century Neurology, a division of Xenoscience has 6 clinical trials on record, with 2 currently active. Their work covers Alzheimer's Disease, Migraine, Episodic Migraine.

Is 21st Century Neurology, a division of Xenoscience accredited by Crixeo Clinical Trials?

21st Century Neurology, a division of Xenoscience has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 21st Century Neurology, a division of Xenoscience?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.